UK-based Signifier Medical Technologies Ltd, which developed a daytime therapy device for sleep disordered breathing called eXcite, announced on 28 July it raised $35m in a series D financing round.
The company’s CEO Akhil Tripathi said the company will use the new funding to “bring our new therapy to millions...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?